Artia Global Partners »

Celcuity shares owned by Artia Global Partners

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 13k 99.74

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Celcuity

Baker Bros. Advisors
NEA Management Company
venBio Select Advisor
Perceptive Advisors
BlackRock
Vanguard Group
Soleus Capital Management
Deerfield Management Company
State Street Corporation
Tang Capital Management
Geode Capital Management
Sio Capital Management
Holocene Advisors
BVF
Goldman Sachs Group

View all funds holding Celcuity